Peter M. Calhoun
Peter M. Calhoun publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Genetics, on topics such as Diabetes Management and Research, Pancreatic function and diabetes and Diabetes and associated disorders.
- World rank
- #103,833 of 7,710,434 ranked researchers
- Rank in United States
- #39,724 of 1,627,098
- Works
- 146
- Citations
- 4.1k
- Citations per work
- 28.2
What does Peter M. Calhoun research?
Peter M. Calhoun's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (13%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10874.0%
- Medicine10370.5%
- Health Professions53.5%
- Everything else2013.4%
- Life Sciences1812.6%
- 1Endocrinology, Diabetes and Metabolism49% of their works
- 2Surgery17% of their works
- 3Genetics13% of their works
- 4General Health Professions4% of their works
- 5Cardiology and Cardiovascular Medicine3% of their works
- 6Obstetrics and Gynecology2% of their works
Research topics
- Diabetes Management and Research
- Pancreatic function and diabetes
- Diabetes and associated disorders
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Mobile Health and mHealth Applications
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
Which keywords describe Peter M. Calhoun's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Type 1 Diabetes, Diabetes, Cardiovascular Disease, Continuous Glucose Monitoring, Hypoglycemia and Diabetes Mellitus.
- Self-Management
- Metabolic Syndrome
- mHealth
- Hyperglycemia
- Type 2 Diabetes
- Genetics
- ß-Cell Dysfunction
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Diabetes
- Insulin Therapy
- Glycemic Control
- Type 1 Diabetes
- Cardiovascular Disease
- Hypoglycemia
- Pancreatic Islets
- Autoimmunity
- Cardiovascular Outcomes
- Critical Care
- Mobile Health
- Insulin Resistance
- Depression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycemic Control1584 topics
- Insulin Therapy1523 topics
- Type 1 Diabetes1462 topics
- Diabetes1183 topics
- Cardiovascular Disease1122 topics
- Continuous Glucose Monitoring1031 topic
- Hypoglycemia1031 topic
- Diabetes Mellitus772 topics
- Pancreatic Islets531 topic
- ß-Cell Dysfunction531 topic
- Autoimmunity431 topic
- Genetics431 topic
- Cardiovascular Outcomes251 topic
- Type 2 Diabetes251 topic
- Critical Care241 topic
- Hyperglycemia241 topic
- Mobile Health101 topic
- mHealth101 topic
- Insulin Resistance91 topic
- Metabolic Syndrome91 topic
- Depression61 topic
- Self-Management61 topic
Where does Peter M. Calhoun work?
Peter M. Calhoun's main affiliation in the publication record is Jaeb Center for Health Research, United States.
How many publications and citations does Peter M. Calhoun have?
OpenAlex counts 146 works and 4,120 citations for Peter M. Calhoun, an h-index of 35, ranking #103,833 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter M. Calhoun. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.